Literature DB >> 18618203

Contents of general practitioner-patient consultations in the treatment of depression.

Michael Linden1, Tatjana Christof, Christiane Rentzsch.   

Abstract

BACKGROUND: Counseling of patients is an indispensable part of any drug treatment and even more so in the treatment of depression.
OBJECTIVE: To describe the content of counseling additional to prescribing an antidepressant drug.
SETTING: Sixty-three general practices from all over Germany. PATIENTS: Three hundred two patients with the diagnosis of either a depressive episode or a recurrent depressive disorder. MEASUREMENTS: Assessment of the content of the physician-patient encounter by content analysis following the pivotal topic method.
DESIGN: Qualitative study embedded in a drug utilization study on mirtazapine.
RESULTS: In the initial sessions general practitioners focused on building a good therapeutic alliance, assessing the symptoms of illness, explaining the course of treatment, assuring medication compliance, and discussing problems of life. In the middle phase of treatment, physicians also dealt with building a therapeutic alliance, medication compliance, and the progress and course of illness. In the last phase relapse prevention was an important topic. Psychological topics were more important than medication topics. Almost no importance was given to management of side effects, change of cognitions, or suicidal tendencies. LIMITATIONS: No information is available on how content was actually discussed. Only encounters were observed where an antidepressant was prescribed.
CONCLUSIONS: Counseling plays an important part in day-to-day encounters of general practitioners. Pharmacotherapy is embedded in comprehensive psychological care. Training programs for general practitioners should be specific in respect to different tasks and parts of the physician-patient encounter (e.g., building a therapeutic alliance, support for life problems or change of cognitions).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18618203      PMCID: PMC2533385          DOI: 10.1007/s11606-008-0648-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  17 in total

Review 1.  General practitioner psychological management of common emotional problems (I): Definitions and literature review.

Authors:  J Cape; C Barker; M Buszewicz; N Pistrang
Journal:  Br J Gen Pract       Date:  2000-04       Impact factor: 5.386

Review 2.  Emotion, cognition, and behavior.

Authors:  R J Dolan
Journal:  Science       Date:  2002-11-08       Impact factor: 47.728

3.  Prevalence, recognition and management of depression in primary care in Germany: the Depression 2000 study.

Authors:  Hans-Ulrich Wittchen; David Pittrow
Journal:  Hum Psychopharmacol       Date:  2002-06       Impact factor: 1.672

4.  Improving depression outcomes in community primary care practice: a randomized trial of the quEST intervention. Quality Enhancement by Strategic Teaming.

Authors:  K Rost; P Nutting; J Smith; J Werner; N Duan
Journal:  J Gen Intern Med       Date:  2001-03       Impact factor: 5.128

5.  Does physician education on depression management improve treatment in primary care?

Authors:  E H Lin; G E Simon; D J Katzelnick; S D Pearson
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  Randomised controlled trial of tailored strategies to implement guidelines for the management of patients with depression in general practice.

Authors:  R Baker; S Reddish; N Robertson; H Hearnshaw; B Jones
Journal:  Br J Gen Pract       Date:  2001-09       Impact factor: 5.386

7.  Interventions to improve provider diagnosis and treatment of mental disorders in primary care. A critical review of the literature.

Authors:  K Kroenke; A Taylor-Vaisey; A J Dietrich; T E Oxman
Journal:  Psychosomatics       Date:  2000 Jan-Feb       Impact factor: 2.386

Review 8.  [Analysis and evaluation of current guidelines for diagnosis and treatment of depressive disorders:].

Authors:  M Härter; I Bermejo; A Aschenbrenner; M Berger
Journal:  Fortschr Neurol Psychiatr       Date:  2001-09       Impact factor: 0.752

9.  Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial.

Authors:  R Peveler; C George; A L Kinmonth; M Campbell; C Thompson
Journal:  BMJ       Date:  1999-09-04

10.  Impact of the ICD-10 Primary Health Care (PHC) diagnostic and management guidelines for mental disorders on detection and outcome in primary care. Cluster randomised controlled trial.

Authors:  Tim Croudace; Jonathan Evans; Glynn Harrison; Deborah J Sharp; Ellen Wilkinson; Gemma McCann; Mathew Spence; Catherine Crilly; Lucy Brindle
Journal:  Br J Psychiatry       Date:  2003-01       Impact factor: 9.319

View more
  4 in total

1.  Facilitating understanding of mental health problems in GP consultations: a qualitative study using taped-assisted recall.

Authors:  John Cape; Connie Geyer; Chris Barker; Nancy Pistrang; Marta Buszewicz; Christopher Dowrick; Peter Salmon
Journal:  Br J Gen Pract       Date:  2010-10-11       Impact factor: 5.386

2.  Guidance by physicians and pharmacists during antidepressant therapy: patients' needs and suggestions for improvement.

Authors:  Mariёtte Nederlof; Daniёlle C Cath; Lennart J Stoker; Toine C G Egberts; Eibert R Heerdink
Journal:  BMC Psychiatry       Date:  2017-12-04       Impact factor: 3.630

3.  Treatment Changes in General Practice Patients With Chronic Mental Disorders Following a Psychiatric-Psychosomatic Consultation.

Authors:  Michael Linden; Beate Muschalla; Nils Noack; Christoph Heintze; Susanne Doepfmer
Journal:  Health Serv Res Manag Epidemiol       Date:  2018-03-15

4.  Educating and informing patients receiving psychopharmacological medications: are family physicians in Pakistan up to the task?

Authors:  Hammad Ashraf Ganatra; Hadi Bhurgri; Roomasa Channa; Fauzia Ahmad Bawany; Syed Nabeel Zafar; Rafia Ishfaq Chaudhry; Syeda Hina Batool; Abdul Basit; Mehmood Asghar; Sarah Saleem; Haider Naqvi
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.